Alimera Sciences To Present At Jefferies Healthcare Conference

        Alimera Sciences To Present At Jefferies Healthcare Conference  PR Newswire  ATLANTA, May 27, 2014  ATLANTA, May 27, 2014 /PRNewswire/ --Alimera Sciences, Inc. (Nasdaq: ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, president and chief executive officer, will present at the Jefferies 2014 Healthcare Conference on Thursday, June 5, 2014 at 1:30 P.M. ET in New York, NY.   The presentation will be webcast live and will be available for access on the Investor Relations section of the corporate website at http://www.alimerasciences.com. For those who are not available to listen to the live broadcast, the webcast will be archived for 90 days.  About Alimera Sciences, Inc.  Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Alimera's European operations are conducted from London by its wholly-owned subsidiary, Alimera Sciences Limited.  ICR, LLC  for Alimera Sciences  John Mills  310-954-1105  John.Mills@icrinc.com  SOURCE Alimera Sciences, Inc.  Website: http://www.alimerasciences.com  
Press spacebar to pause and continue. Press esc to stop.